EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oxidative Stress and Lung Fibrosis: Towards an Adverse Outcome Pathway

Patrudu Makena iD, Tatiana Kikalova, Gaddamanugu L Prasad iD, Sarah A Baxter

International Journal of Molecular Sciences · 06.08.2023 · 24 (15) · 12490

DOI: 10.3390/ijms241512490 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.08.2023. Verfasst von Patrudu Makena und 3 weiteren Autor:innen. Beteiligte Einrichtung: RAI Services Company, P.O. Box 1487, Winston-Salem, NC 27102, USA. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Adverse Outcome Pathways, Lung Injury. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Reynolds American (United States), RAI Services Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung fibrosis is a progressive fatal disease in which deregulated wound healing of lung epithelial cells drives progressive fibrotic changes. Persistent lung injury due to oxidative stress and chronic inflammation are central features of lung fibrosis. Chronic cigarette smoking causes oxidative stress and is a major risk factor for lung fibrosis. The objective of this manuscript is to develop an adverse outcome pathway (AOP) that serves as a framework for investigation of the mechanisms of lung fibrosis due to lung injury caused by inhaled toxicants, including cigarette smoke. Based on the weight of evidence, oxidative stress is proposed as a molecular initiating event (MIE) which leads to increased secretion of proinflammatory and profibrotic mediators (key event 1 (KE1)). At the cellular level, these proinflammatory signals induce the recruitment of inflammatory cells (KE2), which in turn, increase fibroblast proliferation and myofibroblast differentiation (KE3). At the tissue level, an increase in extracellular matrix deposition (KE4) subsequently culminates in lung fibrosis, the adverse outcome. We have also defined a new KE relationship between the MIE and KE3. This AOP provides a mechanistic platform to understand and evaluate how persistent oxidative stress from lung injury may develop into lung fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisAdverse Outcome PathwaysLung InjuryHumansLungOxidative StressFibrosis

Stichwörter der Autor:innen

AOPcigarette smokinginflammationlung fibrosisoxidative stressreactive oxygen species

Autor:innen und Institutionen

  • RAI Services Company, P.O. Box 1487, Winston-Salem, NC 27102, USA.
  • Clarivate Analytics, 1500 Spring Garden, Philadelphia, PA 19130, USA.
  • Former Employee of RAI Services Company, Winston-Salem, NC 27101, USA.
  • Prasad Scientific Consulting LLC, 490 Friendship Place Ct, Lewisville, NC 27023, USA.

ORCID-Profile: Patrudu Makena, Gaddamanugu L Prasad

Förderung

  • Reynolds American (United States)
  • RAI Services Company

Zitieren

APA

Makena, P., Kikalova, T., Prasad, G. L., & Baxter, S. A. (2023). Oxidative Stress and Lung Fibrosis: Towards an Adverse Outcome Pathway. International Journal of Molecular Sciences, 24(15), 12490. https://doi.org/10.3390/ijms241512490

Vancouver

Makena P, Kikalova T, Prasad GL, Baxter SA. Oxidative Stress and Lung Fibrosis: Towards an Adverse Outcome Pathway. International Journal of Molecular Sciences. 2023;24(15):12490. doi:10.3390/ijms241512490

BibTeX
@article{Makena2023,
  author = {Makena, Patrudu and Kikalova, Tatiana and Prasad, Gaddamanugu L and Baxter, Sarah A},
  title = {Oxidative Stress and Lung Fibrosis: Towards an Adverse Outcome Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {15},
  pages = {12490},
  doi = {10.3390/ijms241512490}
}
Kostenlos starten →